OptionsHouse

Options Trading News

November 7, 2011  Mon 7:26 AM CT

TKLC: SEE CHART GET CHAIN FIND STRATEGIES
Deal Values Tekelec at $780 Million

Tekelec, a maker of networking technology, agreed to be purchased by Siris Capital for $11 a share. TKLC pops 11 percent before the bell.

Pharmasset Lifted by Hep-C Data

Pharmasset released data over the weekend showing promise of its PSI-7977 compound in fighting Hepatitis C. Those results were from a Phase II trial, and now support the case for more advanced Phase III testing. VRUS climbs 9 percent in the premarket.

Omnivision Lowers Outlook

Omnivision Technologies cut its outlook in a preliminary earnings release because of an "unexpected cutback in orders." Management now sees revenue of now more than $217 million, down from an earlier $255-275 million estimate. OVTI drops 17 percent in the pre.
Share this article with your friends


OptionsHouse

TRADING WEEKLY OPTIONS

The fastest money in the market
View full report »

Premium Services

Archived Webinar

Education & Strategy

Long synthetic call

Long and short Synthetic stock are two of the six basic synthetic positions that exist. Number three on our list is the Synthetic Long Call...

View more education articles »